[go: up one dir, main page]

AR032974A1 - Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad - Google Patents

Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad

Info

Publication number
AR032974A1
AR032974A1 ARP020100850A ARP020100850A AR032974A1 AR 032974 A1 AR032974 A1 AR 032974A1 AR P020100850 A ARP020100850 A AR P020100850A AR P020100850 A ARP020100850 A AR P020100850A AR 032974 A1 AR032974 A1 AR 032974A1
Authority
AR
Argentina
Prior art keywords
age
composition
deficiencies related
increases longevity
physiological deficiencies
Prior art date
Application number
ARP020100850A
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of AR032974A1 publication Critical patent/AR032974A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente se relaciona con una composicion de alimento disenada para evitar o restaurar las deficiencias funcionales relacionadas con la edad en los mamíferos al revertir las alteraciones de expresion de genes relacionados con la edad, el cual comprende una combinacion que es capaz de imitar los efectos de la restriccion calorica sobre la expresion de genes, la combinacion contiene por lo menos una molécula que estimula el metabolismo de energía de la célula y por lo menos un antioxidante.
ARP020100850A 2001-03-09 2002-03-08 Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad AR032974A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01200871 2001-03-09

Publications (1)

Publication Number Publication Date
AR032974A1 true AR032974A1 (es) 2003-12-03

Family

ID=8179979

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100850A AR032974A1 (es) 2001-03-09 2002-03-08 Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad

Country Status (17)

Country Link
US (2) US20040047896A1 (es)
EP (1) EP1372412A2 (es)
JP (1) JP2004519241A (es)
KR (1) KR20030088453A (es)
CN (1) CN1638650A (es)
AR (1) AR032974A1 (es)
AU (1) AU2008201296A1 (es)
BR (1) BR0207948A (es)
CA (1) CA2439078C (es)
EA (1) EA006429B1 (es)
IL (2) IL157367A0 (es)
MX (1) MXPA03007802A (es)
NO (1) NO20033941L (es)
PE (1) PE20020987A1 (es)
PL (1) PL363426A1 (es)
WO (1) WO2002071874A2 (es)
ZA (1) ZA200307865B (es)

Families Citing this family (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
EP1243273A1 (en) † 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
CO5400144A1 (es) 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
ATE492166T1 (de) * 2002-04-05 2011-01-15 Nestle Sa Zusammensetzungen und verfahren zur verbesserung von lipidassimilation in haustieren
JP5013673B2 (ja) * 2002-09-09 2012-08-29 ネステク ソシエテ アノニム 毛髪および外被品質を改良するための経口投与可能な組成物
FI20022175A0 (fi) * 2002-12-10 2002-12-10 Labmax Oy Elintarvikeöljyvalmiste ja sen käyttö
US20040191775A1 (en) * 2003-03-12 2004-09-30 Spindler Stephen R. Methods of analyzing genes affected by caloric restriction or caloric restriction mimetics
US7332178B2 (en) * 2003-04-25 2008-02-19 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US8192733B2 (en) * 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7749509B2 (en) * 2003-08-29 2010-07-06 Cobb And Company, Llp Treatment of autism using probiotic composition
US7731976B2 (en) * 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
US8652532B2 (en) * 2003-11-21 2014-02-18 Nestec S.A. Food composition comprising glucosamine
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
CN110522717A (zh) 2004-01-22 2019-12-03 迈阿密大学 局部辅酶q10制剂及其使用方法
KR20060132667A (ko) * 2004-01-28 2006-12-21 네스텍소시에테아노님 피부 상태 개선 및 피부 질환 예방을 위한 영양 조성물
JP2007289001A (ja) * 2004-05-10 2007-11-08 Toyo Shinyaku:Kk ポリフェノールを含有する食品
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
AU2012211482B2 (en) * 2004-05-27 2014-08-21 Mars, Incorporated Pet food compositions and methods
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
JP2006014730A (ja) * 2004-05-31 2006-01-19 Toyo Shinyaku:Kk 食品
WO2005123058A1 (ja) * 2004-06-15 2005-12-29 Osaka Prefectural Government 老化防止剤
ES2304585T3 (es) * 2004-09-21 2008-10-16 Nestec S.A. Longevidad mejorada de gatos de avanzada edad.
EP1645276A1 (en) * 2004-10-08 2006-04-12 Wageningen Centre for Food Sciences Treatment of neurodegenerative disorders
AU2005304546B2 (en) * 2004-11-09 2011-07-21 Hill's Pet Nutrition, Inc. Use of antioxidants for gene modulation
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
BRPI0518580A2 (pt) * 2004-11-24 2008-11-25 Hills Pet Nutrition Inc mÉtodo para melhorar a depuraÇço hepÁtica de substÂncias xenobiàticas em um animal, kit adequado para alimentar Ácido lipàico a um animal, meio para comunicar informaÇço, composiÇço, e, uso da composiÇço que compreende Ácido lipàico
JP4820760B2 (ja) * 2004-12-03 2011-11-24 キッコーマン株式会社 水溶性乾燥食品
WO2006066404A1 (en) * 2004-12-21 2006-06-29 Critical Care Connections, Inc. Therapeutic nutrient compositions or combinations and methods of their use
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
AU2005322015B2 (en) * 2004-12-29 2010-02-25 Hill's Pet Nutrition, Inc. Methods for inhibiting a decline in learning and/or memory in animals
CN102907561A (zh) * 2004-12-30 2013-02-06 希尔氏宠物营养品公司 提高老年动物的生活质量的方法
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US20070118295A1 (en) * 2005-03-02 2007-05-24 Al-Murrani Samer Waleed Khedhe Methods and Systems for Designing Animal Food Compositions
US7198834B2 (en) * 2005-03-22 2007-04-03 Hewlett-Packard Development Company, L.P. Imaging media including interference layer for generating human-readable marking on optical media
JP5451065B2 (ja) * 2005-04-19 2014-03-26 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 腎疾患の予防および治療のための方法および組成物
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
US20090209647A1 (en) * 2005-06-14 2009-08-20 Nestec S.A. Nutritional method
WO2007009111A1 (en) 2005-07-14 2007-01-18 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
US8492432B2 (en) 2005-08-17 2013-07-23 Hill's Pet Nutrition, Inc. Methods for the treatment of kidney disease
WO2007029730A1 (ja) * 2005-09-06 2007-03-15 Meiji Dairies Corporation 老人性貧血を防止又は治療するためのアミノ酸組成物
EP1927349A4 (en) 2005-09-22 2010-05-05 Kaneka Corp COMPOSITION FOR EXTENDING LIFE AND METHOD FOR EXTENDING LIFE
WO2007038466A2 (en) * 2005-09-27 2007-04-05 Cobb & Company Treatment of bipolar disorder utilizing anti-fungal compositions
WO2007041641A1 (en) * 2005-10-03 2007-04-12 University Of Tennessee Research Foundation Methods of reducing the production of reactive oxygen species and methods of screening or identifying compounds and compositions that reduce the production of reactive oxygen species
AU2007211625B2 (en) 2006-02-01 2012-08-23 Nestec S.A. Nutritional system and methods for increasing longevity
RU2445362C2 (ru) * 2006-02-15 2012-03-20 Нестек С.А. Применение bifidobacterium longum в производстве лекарственного средства или терапевтической питательной композиции для лечения воспалительного заболевания кишечника у млекопитающего и для ослабления воспаления кишечника, связанного с пищевыми аллергенами, у млекопитающего
US7960605B2 (en) 2006-03-17 2011-06-14 BioMaker Pharmaceuticals, Inc. Methods for testing for caloric restriction (CR) mimetics
EP2004201B1 (en) * 2006-03-29 2018-08-08 Nestec S.A. Dietary supplements containing probiotics
WO2008007245A2 (en) * 2006-06-07 2008-01-17 The Iams Company Natural preservatives for preservation of perishable products
US20070286925A1 (en) * 2006-06-08 2007-12-13 The Procter & Gamble Company Composition for improving eye health
JP5281234B2 (ja) * 2006-06-27 2013-09-04 ポーラ化成工業株式会社 毛様体過緊張による疲れ目の改善・予防のための経口投与組成物
WO2008004340A1 (en) * 2006-07-05 2008-01-10 Kao Corporation Senescence inhibitor
JP2008013473A (ja) * 2006-07-05 2008-01-24 Kao Corp 筋機能低下抑制剤
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
US20090038024A1 (en) * 2007-06-19 2009-02-05 The Regents Of The University Of California Cap/sorbs1 and diabetes
DE102007030495A1 (de) * 2007-06-30 2009-01-15 Alzchem Trostberg Gmbh Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der Gedächtnisleistung, der Merkfähigkeit, des Langzeitgedächtnisses und zur Vorbeugung geistiger Ermüdungszustände
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
US20100129467A9 (en) * 2007-08-31 2010-05-27 Albritton Iv Ford D Nutritional supplement
CN101909611A (zh) 2007-10-26 2010-12-08 凯马福尔公司 增强免疫应答的组合物和方法
JPWO2009066562A1 (ja) * 2007-11-20 2011-04-07 明治乳業株式会社 赤血球系幹細胞の分化促進剤及び／又は増殖促進剤、並びに老人性貧血を防止又は治療するためのメチオニンの使用及びメチオニンを含む組成物
CA2712987C (en) * 2008-02-07 2016-05-17 Nestec S.A. Compositions and methods for influencing recovery from strenuous physical activity
EP3015104A1 (en) 2008-04-11 2016-05-04 Berg LLC Methods and use of inducing apoptosis in cancer cells
EP2123171A1 (de) * 2008-05-20 2009-11-25 Otto Thannesberger Futtermischung
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
EP2320752A1 (en) * 2008-07-18 2011-05-18 Hill's Pet Nutrition, Inc. Method for enhancing the quality of life of a senior animal
EP2320889A4 (en) * 2008-08-15 2016-09-21 Nestec Sa METHOD FOR INCREASING THE CHANGE OF ENERGY REPLACEMENT
US20100112181A1 (en) * 2008-10-30 2010-05-06 Matthew Joel Taylor Recovery of Antioxidants from Decaffeination Process
US20100112136A1 (en) * 2008-10-30 2010-05-06 Susan Ruth Ward Pet food composition comprising an antioxidant component
EP2216035A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus CNCM I-4096 and weight control
EP2216034A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus helveticus CNCM I-4095 and weight control
WO2010124391A1 (en) * 2009-04-30 2010-11-04 Chemaphor Inc. Methods and compositions for improving the health of animals
SG10201402287TA (en) 2009-05-11 2014-07-30 Berg Llc Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
US9173423B2 (en) * 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
RU2558540C2 (ru) * 2010-01-06 2015-08-10 Нестек С.А. Диетические режимы, пригодные для имитации ограничения калорий
EP2444083A1 (en) * 2010-10-21 2012-04-25 Nestec S.A. Cysteine and food intake
RU2593716C2 (ru) * 2010-11-11 2016-08-10 Нестек С.А. Замороженные кондитерские изделия, содержащие пробиотические микроорганизмы
EP2452576A1 (en) * 2010-11-11 2012-05-16 Nestec S.A. Extruded non-replicating probiotic micro-organisms and their health benefits
MY166946A (en) * 2010-12-31 2018-07-25 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
KR101933732B1 (ko) 2011-04-04 2018-12-28 버그 엘엘씨 중추 신경 시스템 종양들의 치료 방법
EP2532355A1 (en) * 2011-06-06 2012-12-12 Nestec S.A. Chicory for prevention and treatment of neurodegeneration
WO2012174484A2 (en) * 2011-06-15 2012-12-20 Nse Products, Inc. Identifying markers of caloric restriction and caloric restriction mimetics
EP2731599B1 (en) 2011-07-15 2018-10-31 NuSirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
EP2753311B1 (en) * 2011-09-09 2020-07-29 Kemin Industries, Inc. Antioxidant formulations
FR2982460B1 (fr) * 2011-11-14 2016-08-05 Virbac Sa Produits pour administration orale comprenant des extraits de grenade punica granatum, destines a un animal de compagnie, et ses applications
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
KR101476236B1 (ko) * 2012-08-16 2014-12-24 경희대학교 산학협력단 노화 및 치매의 예방 및/또는 치료 활성을 갖는 유산균
CN102783568B (zh) * 2012-08-29 2014-05-14 山东中医药大学 一种饲料添加剂
CN108452311A (zh) 2012-11-13 2018-08-28 纽斯尔特科学公司 用于增强能量代谢的组合物和方法
CN108271917A (zh) 2013-03-08 2018-07-13 艾斯姆食品公司 大米蛋白补充剂
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
WO2014149280A1 (en) * 2013-03-15 2014-09-25 Nusirt Sciences, Inc. Treatment of pets with sirtuin activators
CN105228627B (zh) 2013-03-15 2018-07-13 纽斯尔特科学公司 亮氨酸和烟酸降低脂质水平
WO2014168993A1 (en) 2013-04-08 2014-10-16 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
ES2825083T3 (es) 2013-09-04 2021-05-14 Berg Llc Métodos de tratamiento contra el cáncer mediante infusión continua de coenzima Q10
CN103461674B (zh) * 2013-09-23 2014-12-31 大连圣弘医药有限公司 一种能够有效活化宠物关节的宠物功能食品配方及其制备方法
US20150164833A1 (en) * 2013-12-17 2015-06-18 Mead Johnson Nutrition Company Nutritional composition containing a neurologic component of ursolic acid and uses thereof
SG11201607075TA (en) 2014-02-27 2016-09-29 Nusirt Sciences Inc Compositions and methods for the reduction or prevention of hepatic steatosis
AU2015202755B2 (en) * 2014-05-21 2017-05-04 Medlab Ip Pty Ltd Probiotic combinations and uses thereof
BR112017017190B1 (pt) 2015-02-16 2022-08-30 Mars, Incorporated Método para produzir um alimento para animais de estimação
US11388914B2 (en) 2015-04-28 2022-07-19 Mars, Incorporated Process of preparing a wet pet food, wet pet food produced by the process and uses thereof
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
EP3434783A4 (en) 2016-03-26 2019-11-06 Kawasaki Gakuen Educational Foundation MITOCHONDRIAL BIOMARKER FOR AGING DISPLAY
USD806351S1 (en) 2016-09-06 2018-01-02 Mars, Incorporated Food product
USD805728S1 (en) 2016-09-06 2017-12-26 Mars, Incorporated Food product
IT201600111275A1 (it) * 2016-11-04 2018-05-04 Centro Dermatologico S R L Metodo di trattamento cosmetico
GB201701417D0 (en) 2017-01-27 2017-03-15 Mars Inc Pet food
US11284640B2 (en) * 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
IT201800000890A1 (it) 2018-01-15 2019-07-15 Sirt500 Sagl Composizione nutraceutica per l’attivazione delle sirtuine con effetto anti-aging/reverse-aging
CN109045059A (zh) * 2018-08-01 2018-12-21 泓博元生命科技（深圳）有限公司 一种抗衰老、提高男性精力的组合物、制剂及其制备方法与应用
WO2020067368A1 (ja) * 2018-09-26 2020-04-02 株式会社明治 ミトコンドリア機能改善剤
EP3873415A1 (en) 2018-11-02 2021-09-08 Unilever Global Ip Limited Bioenergetic nicotinic acid glycerol esters, compositions and methods of using same
EP3876741A4 (en) * 2018-11-09 2022-08-31 L-Nutra NUTRIENT BAR FOR INTERMITTENT FASTING SIMULATE
EP3996668B1 (en) * 2019-07-12 2024-10-16 Unilever Global IP Limited Topical compositions and methods of using same against mitochondrial fragmentation
CN112079911B (zh) * 2020-09-04 2022-04-08 扬州大学 一种促进银杏类黄酮合成的关键基因GbMYB6及其表达的蛋白、载体和应用
CN112080507B (zh) * 2020-09-04 2022-04-08 扬州大学 一种调控银杏类黄酮合成的关键基因GbMYB4及其表达的蛋白、载体和应用
US20240148026A1 (en) * 2021-03-17 2024-05-09 Hyo Gyoung Yu Liquid-phase, supplementary feed composition containing coenzyme q10
CN116262121A (zh) * 2021-12-15 2023-06-16 南湖实验室 牛磺熊去氧胆酸及其钠盐在抗衰老和/或延长寿命中的应用
KR102779455B1 (ko) * 2024-09-03 2025-03-13 이대훈 반려동물의 눈 기능과 눈물자국 개선용 조성물 및 이를 포함하는 반려동물용 영양제

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156769B (it) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di altri acil derivati della carnitina
US4330557A (en) * 1979-05-21 1982-05-18 Claudio Cavazza Acyl-carnitine and use thereof in parenteral administration of triglycerides
US4921877A (en) * 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US4883672A (en) * 1988-04-29 1989-11-28 Shug Austin L Method for preventing diet induced carnitine deficiency in domesticated dogs and cats
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6022867A (en) * 1996-11-27 2000-02-08 Showa Denko Kabushiki Kaisha Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals
ES2201467T3 (es) * 1997-03-27 2004-03-16 Michael J. Sole Composicion nutritiva para la mejora energetica de la celula.
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US5973004A (en) * 1997-04-04 1999-10-26 Howard; James R. L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism
FR2761887B1 (fr) * 1997-04-11 1999-06-18 Roland Asmar Medicament visant a la prevention multifactorielle des maladies cardiovasculaires
US5916912A (en) * 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
DE19806890A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische und dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Antioxidans sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
US5926849A (en) * 1998-03-31 1999-07-27 Boyle; Kevin J. Baseball cap with a channeled, laminated inside head band
US5932258A (en) * 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
IT1302307B1 (it) * 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
IT1304406B1 (it) * 1998-10-21 2001-03-19 Danital Italia S R L Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
US6562869B1 (en) * 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
US6335361B1 (en) * 1999-11-03 2002-01-01 Juvenon Inc. Method of treating benign forgetfulness
US20020146400A1 (en) * 2000-01-07 2002-10-10 Cincotta Anthony H. Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity
CA2399319A1 (en) * 2000-01-25 2001-08-16 Nathan D. Hamilton Nutritional supplements for aged pets
US6277842B1 (en) * 2000-10-17 2001-08-21 James Alexander Carthron Dietary supplemental method for fat and weight reduction
JP5013673B2 (ja) * 2002-09-09 2012-08-29 ネステク ソシエテ アノニム 毛髪および外被品質を改良するための経口投与可能な組成物
KR20060132667A (ko) * 2004-01-28 2006-12-21 네스텍소시에테아노님 피부 상태 개선 및 피부 질환 예방을 위한 영양 조성물

Also Published As

Publication number Publication date
CA2439078A1 (en) 2002-09-19
PL363426A1 (en) 2004-11-15
EA200300994A1 (ru) 2004-02-26
CA2439078C (en) 2009-08-25
US20050100617A1 (en) 2005-05-12
WO2002071874A3 (en) 2003-01-09
EA006429B1 (ru) 2005-12-29
JP2004519241A (ja) 2004-07-02
PE20020987A1 (es) 2002-12-17
IL157367A0 (en) 2004-02-19
NO20033941D0 (no) 2003-09-05
NO20033941L (no) 2003-09-05
KR20030088453A (ko) 2003-11-19
BR0207948A (pt) 2004-07-27
EP1372412A2 (en) 2004-01-02
IL157367A (en) 2006-07-05
ZA200307865B (en) 2005-01-10
MXPA03007802A (es) 2003-12-08
AU2008201296A1 (en) 2008-04-17
CN1638650A (zh) 2005-07-13
US20040047896A1 (en) 2004-03-11
WO2002071874A2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
AR032974A1 (es) Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad
BRPI0409591A (pt) composições com múltiplas fases lìquidas visualmente distintas
GT200200165A (es) Compuestos biciclicos aromaticos sustituidos con amino-alquilo, procedimiento para su preparacionysuutilizacioncomomedicamento
AR031283A1 (es) Composicion y metodo de dieta para animales
BRPI0515316A (pt) compostos de imidazoquinolina
UY25242A1 (es) Inhibidores de benzotiazol de la proteína tirosina cinasa
AR022076A1 (es) Composicion antioxidante constituida por acetil l-carnitina y acido alfa-lipoico para mejorar el aprovechamiento metabolico de la glucosa
AR035567A1 (es) Composiciones que comprenden bloqueadores de transferencia de celula renal l-dopa para el tratamiento de la enfermedad de parkinson
AR035293A1 (es) Composicion oftalmica.
MXPA05000122A (es) Compuestos utiles para la inhibicion de aldehido-deshidrogenasa.
AR035284A1 (es) Formulaciones en combinacion de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilizacion
MXPA05002652A (es) Composicion oralmente administrable para mejorar la calidad de la piel.
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
AR048051A1 (es) Composiciones para obtener beneficios en la piel con el uso de intermediarios del metabolismo celular
AR005431A1 (es) Ozocolorantes reactivos con componentes de copulacion de la serie de los acidos aminonaftalensulfonicos, naftilaminas utilizadas y productos intermediosformados, en la preparacion de dichos ozocolorantes y utilizacion de los ozocolorantes.
CR9853A (es) Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion
PA8542201A1 (es) Inhibidores de pcp basados en acidos-3-heterociclilpropanohidroxamicos
BRPI0407141A (pt) Conversor de força no modo comutador
ES2182084T3 (es) Compuestos con esqueletos de colquicina, su uso como medicamentos y composiciones que los contienen.
UY27201A1 (es) Composición que mejora las deficiencias fisiológicas relacionadas con la edad y que incrementa la longevidad
BR0008471A (pt) Irradiador de antena
AR045286A1 (es) Una composicion para la coloracion del cabello
BR0302430A (pt) Solução quimiluminescente baseada em ácidos tetracarboxìlicos perileno disubstituìdos, seus dianidros e diimidas
AR033463A1 (es) Una composicion para tenir el cabello
BR8202424U (pt) Letreiro de taxi com indicativo de uso

Legal Events

Date Code Title Description
FB Suspension of granting procedure